Viewing Study NCT01842620


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-01-10 @ 12:08 AM
Study NCT ID: NCT01842620
Status: COMPLETED
Last Update Posted: 2017-12-22
First Post: 2013-04-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: OXEMETâ„¢ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metformin View
None Bioequivalence View